Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Nectar Lifescience Ltd (NECLIFE) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Pharmaceutical ManufacturingProduction of oral and sterile cephalosporin APIs, phytochemicals, and empty hard gelatin capsules.Global leader in certain APIs; multi-purpose plants adaptable to market needs; regulatory compliant manufacturing facilities.B2B pharmaceutical companies in domestic and international markets.Sterile APIs and capsule manufacturing segments have higher margins due to specialized processes.1669100Revenue from sale of pharmaceutical APIs, capsules and contract manufacturing services to pharma companies.Sales based on contracts and orders with negotiated pricing; recurring supply agreements.Global antibiotic demand, expansion into sterile injectables and phytochemicals, new capsule products.Cefixime Trihydrate, Cefuroxime Axetil, Cefpodoxime Proxetil, Nexxicap MintyTM, Nexxicap PearlTM

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions